A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : The aim of this study was to de ter mi ne the pre va len ce of the HFE ge ne muta ti ons (C282Y, S65C and H63D) in pa ti ents with crypto ge nic cirr ho sis, he moc hro ma to sis and healthy con trols. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : The exon 2 and exon 4 of the HFE ge ne we re amp li fi ed by poly me ra se cha in re ac ti on (PCR) in the DNA samp les of 18 crypto ge nic cirr ho tic and 11 he mochro ma to sis pa ti ents, and 141 he althy con trol in di vi du als.Then the res tric ti on frag ment length poly morp hism (RFLP) met hod was used to de tect the mu ta ti ons. R Re e s su ul lt ts s: : The fre qu en ci es of C282Y, S65C and H63D mu ta ti ons we re fo und as 0.0, 0.0, 0.12 res pec ti vely in he althy Tur kish popu la ti on and 0.0, 0.0, and 0.11 res pec ti vely in crypto ge nic cirr ho tic pa ti ents. We al so scre e ned 11 he moc hro ma to sis pa ti ents for the se mu ta ti ons, and the fre qu en ci es of the mu ta ti ons we re fo und as 0.0 for C282Y, 0.0 for S65C, and 0.27 for H63D mu ta ti on. The re was no dif fe ren ce bet we en the con trol gro up and crypto ge nic cirr ho sis gro up. Ho we ver, we fo und dif fe ren ces in the fre qu ency of the H63D mu ta ti on bet we en the con trol gro up and he moc hro ma to sis gro up. C Co on nc c l lu u s si i o on n: : The fre qu en ci es of the C282Y and S65C mu ta ti ons we re fo und as 0.0 in Tur kish po pu la ti on and in the pa ti ents with crypto ge nic cirr ho sis similar to ot her Asi an po pu la ti ons. Ho we ver, the fre qu ency of the H63D mu ta ti on was hig her than pre vi o usly re por ted in Asi an po pu la ti ons. The se re sults suggest that the H63D mu ta ti on may be res pon sib le for the he re di tary he moc hro ma to sis in Tur kish po pu la ti on. K Ke ey y W Wo or rd ds s: : Li ver cirr ho sis; he moc hro ma to sis; DNA mu ta ti o nal analy sis; poly me ra se cha in re ac ti on; res tric ti on map ping Ö ÖZ ZE ET T A Am ma aç ç: : Bu ça lış ma nın ama cı, krip to je nik si roz lu, he mok ro ma to zis li has ta lar da ve sağ lık lı kontrol bi rey ler de HFE gen mu tas yon la rı (C282Y, S65C ve H63D) sık lı ğı nın be lir len me siy di. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : On sekiz krip to je nik si roz lu ve 11 he mok ro ma to zis li has ta ile 141 sağ lık lı kon trol bi reyin DNA ör nek le rin de HFE ge ni nin ek zon 2 ve ek zon 4 po li me raz zin cir re ak si yo nu (PCR) ile ço -ğal tıl dı.Son ra, mu tas yon la rı sap ta mak için res trik si yon frag man tı uzun luk po li mor fiz mi (RFLP) yön te mi kul la nıl dı. B Bu ul l g gu u l la ar r: : C282Y, S65C ve H63D mu tas yon la rı nın sık lı ğı sağ lık lı Türk po pü lasyon da sı ra sıy la 0.0, 0.0, 0.12 ve krip to je nik si roz lu has ta lar da sı ra sıy la 0.0, 0.0, 0,11 ola rak bu lundu. Ay rı ca, 11 he mok ro ma to zis li has ta yı bu mu tas yon lar açı sın dan ta ra dık ve mu tas yon sık lık la rı C282Y için 0.0; S65C için 0,0; ve H63D mu tas yo nu için 0,27 ola rak bu lun du.Kon trol gru bu ve kripto je nik si roz gru bu ara sın da fark yok tu. An cak, kon trol gru bu ve he mok ro ma to zis li grup ara sın da H63D mu tas yon sık lı ğı açı sın dan fark lı lık lar bu lun du. S So o n nu uç ç: : C282Y ve S65C mu tas yon sık lık la rı di ğer As ya po pü las yon la rın da ol du ğu gi bi Türk po pü las yo nu ve krip to je nik si roz lu has ta lar da 0.0 ola rak bu lun du.An cak, H63D mu tas yon sık lı ğı da ha ön ce As ya po pü las yon la rın da ra por edi len lerden da ha yük sek ti.Bu so nuç lar H63D mu tas yo nu nun Türk po pü las yo nun da ka lıt sal he mok ro ma tozis ten so rum lu ola bi le ce ği ni gös ter mek te dir.
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A An na ah h t ta ar r K Ke e l li i m me e l le er r: : Ka ra ci ğer si ro zu; he mok ro ma to zis; DNA mu tas yon ana li zi; po li me raz zin cir re ak si yo nu; res trik si yon ha ri ta la ma sı T Tu ur rk ki iy ye e K Kl li in ni ik kl le er ri i J J M Me ed d S Sc ci i 2 20 01 10 0; ;3 30 0( (6 6 2 Three missense mutations (C282Y, S65C and H63D) have been described on the HFE gene in patients suffering from hemochromatosis on the basis of phenotypic data. 3 The major mutation, C282Y, is a G→A transition at nucleotide 845 of the open reading frame that changes the 282 cysteine to tyrosine. It accounts for 80% to 90% of hereditary hemochromatosis chromosomes in the world. The second mutation, S65C, a substitution in exon 2, altering the 65 amino acid serine to cysteine, has been associated with the development of a mild form of iron overload. The third mutation, H63D, is a C→G transition in codon 63, resulting in the substitution of histidine for aspartic acid. Because of its high frequency in the general population, its role in the disease remains uncertain. This variant could indeed be a minor mutation causing iron overload with a low penetrance. 4, 5 The aim of this study was to screen the HFE gene mutations (C282Y, S65C, and H63D) as a genetic factor in the patients with cryptogenic cirrhosis as compared to the patients with hemochromatosis and the healthy controls.
MATERIAL AND METHODS

PATIENTS
Eighteen cryptogenic cirrhotic patients (10 females, eight males; mean age: 49.06 years, range: 19-72) and 141 randomly selected healthy volunteers (92 females, 49 males; mean age: 31.01 years, range: 19-61) who were living in Antalya were included in the study. Additionally, we screened 11 patients with hemochromatosis. Patients with crytogenic cirrhosis selected after excluding known reasons of cirrhosis including hepatitis virus infections (HBV and HCV), excessive alcohol consumption, alpha--1--antitrypsin deficiency, autoantibodies such as antismooth muscle antibody, anti-nuclear antibody and anti-mitochondrial antibody, Wilson's disease, and hemochromatosis. Hemochromatosis patients were included into the study according to the absence of secondary causes of iron overload (anemia, thalassemia major, or dietary iron overload), transferrin saturation greater than 50% and ferritin levels greater than 400 ng/ml. Patient and control groups completed a detailed health questionnaire including demographic data, and signed an informed consent that was approved by the Ethical Committee of Akdeniz University Medical School. Genomic DNA was isolated from peripheral blood cells according to the protocol described previously. 6 The HFE gene mutations, C282Y, S65C and H63D, were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique using specific primers and restriction enzymes. The same primers were used for S65C and H63D mutations. The primers of the PCR amplifications for the C282Y, mutations were designed as C282Y-forward 5'-TGG CAA GGG TAA ACA GAT CC -3' and C282Y-reverse 5'-CTC AGG CAC TCC TCT CAA CC -3'. The S65C and H63D primers were H63D/S65C-forward 5'-ACA TGG TTA AGG CCT GTT GC -3', and H63D/S65C-reverse 5'-GCC ACA TCT GGC TTG AAA TT -3'. 2, 7 We used a total volume of 50 ml per reaction which included 10x PCR buffer (160 mM (NH4) 2 SO 4 , 670 mM Tris HCl pH 8.8, 0.1% Tween-20), 20 mM MgSO 4 , 20 mM each primers, 100 mM dNTP mix, 250 ng template DNA, 5 U/ml Taq DNA polymerase (Bioron and BioGen). The PCR was carried out in a thermal cycler (Techne Genius). Amplification conditions consisted of 10 minutes initial denaturation at 95 0 C followed by 40 cycles of denaturation at 95 0 C for 1 minute, annealing at 55 0 C for 1 minute and extension at 72 0 C for 1 minute, the final extension at 72 0 C for 10 minutes. The fragment sizes for C282Y and H63D/S65C were 388 bp and 200 bp, respectively. The PCR products were digested with the restriction enzymes Rsa I, Hinf I and Mbo I (Nde II) (Roche) at 37 0 C to identify the C282Y, S65C and H63D mutations, respectively. The restriction fragments of Turkiye Klinikleri J Med Sci 2010;30 (6) the PCR products were separated by 3% agarose gel electrophoresis stained with ethidium bromide and photographed under UV light.
Serum iron concentration and total iron binding capacity (TIBC) were measured by photometric technique with autoanalyser. Transferrin saturation (TS) was calculated as the ratio of serum iron concentration to TIBC. Serum ferritin measurements were performed by ECL technique in the Central Laboratory of Akdeniz University Medical School.
RESULTS
A total of 18 cryptogenic cirrhotic patients (10 females, eight males) over the age of 19 years (range: 19-72 years; mean: 49.06 years,) and 141 healthy control subjects (92 females, 49 males) over the age of 19 years (range: 19-61 years; mean: 30.01 years) were evaluated for C282Y, H63D and S65C of the HFE gene mutations. The allelic frequencies of the mutations determined in the patient group and in the control subjects are given in Tables 1 and 2 . All of the patients and the control group were found to be homozygous wild type for C282Y and S65C mutations. One heterozygous (5.56%) and one homozygous (5.56%) for the H63D mutation was found in the patient group. Among 141 control subjects, two (1.42%) were homozygous and 30 (21.28%) were heterozygous for the H63D mutation. Additionally, two of the 11 patients with hemochromatosis were heterozygous; other two were homozygous for the H63D mutation. Neither the C282Y nor S65C were found in the hemochromatosis patients. The allelic frequency of the H63D showed significant differences between hemochromatosis (27%) and cryptogenic chirrhosis (8.33%) patients and the controls (12.06%). The H63D genotypes and biochemical iron parameters of the patient and control groups are summarized in Table 3 .
The patients who were homozygous for the H63D mutation had higher ferritin, serum iron concentration and transferin saturation values when compared to normal and heterozygous individuals for the same mutation with the exception of total iron binding capacity. Interestingly, a patient who had cryptogenic cirrhosis and heterozygous for H63D had lower ferritin, serum iron level and transferritin saturation than homozygous normal control individuls. Examination of the patient's records showed that the patient developed esophageal varices in grade IV and antral gastritis according to the results of esophagoscopy and gastroscopy, respectively.
DISCUSSION
In this study, we report the results of screening for HFE gene mutations (C282Y, S65C and H63D) in 18 patients with cryptogenic cirrhosis and in 141 healthy controls from Antalya, Turkey. The frequencies of these HFE gene mutations in the cryptogenic cirrhosis were compared with to hemochromatosis and control groups. Although many screening studies related to hereditary hemochromatosis have been performed in different populations, there is a few population-based studies in Turkish population in the different perspectives. [8] [9] [10] [11] The results of these studies show that C282Y and S65C mutations are very rare or absent in Turkish population. [8] [9] [10] However, it has been reported that the frequency of the C282Y mutation is high in people of Angloceltic origin. tation is also absent in populations of Asia. 14, 15 The results of the present study showed the absence of the C282Y and S65C mutations and high prevalence of the H63D mutation in both cryptogenic cirrhosis and hemochromatosis and control individuals.However, Lal et al. secreened the C282Y mutation in 22 and 26 patients diagnosised as cryptogenic cirrhosis and hepatitis C cirrhosis, respectively. 16 They found one heterozygous case for the C282Y mutation among the crptogenic cirrhosis patients. On the other hand, three of the 26 hepatitis C cirrhotic cases were detected as heterozygous mutant for the C282Y mutation. 16 The importance of being homozygous and heterozygous for H63D is not well understood. In this study, the frequency of the H63D mutation was found to be higher than other Asian populations with 12.06%. 14, 15 Therefore, the H63D mutation may play a role in expression and progression of the cryptic cirrhosis and hereditary hemochromatosis, if it is associated with intrinsic and extrinsic factors in Turkish population.
Iron metabolism is regulated by genetic, physiological, and environmental factors. In our study, the patients with cryptogenic cirrhosis who were homozygous for the H63D mutation have had higher ferritin, serum iron concentration and transferin saturation than normal and heterozygous individuals for H63D mutation. The reason of low level ferritin, serum iron concentration and transferrine saturation of the patient that have heterozygous H63D mutation may be related to the loss of blood from esophageal varices. In literature, there are differetent studies performed to determine association between cirrhosis and HFE gene mutations. [17] [18] [19] [20] Willis et al. have secreened the HFE gene mutations (C282Y and H63D) in 190 cirrhotic patients using polymerase chain reaction. 18 Of the 190 patients with cirrhosis, five (2.6%) patients and six of the cases (3.1%) were found to be homozygous mutants for the C282Y mutation and C282Y/H63D compound heterozygous, respectively. These mutations were significantly more frequent than the control group. 18 In our opinion, if more cases would have been investigated, the H63D mutation would have been related to iron parameters in the diseases such as cryptogenic cirrhosis and hemochromatosis.
In conclusion, the results of our study suggest that the C282Y and S65C mutations of the HFE gene are rare or absent in Turkish population. The frequency of the H63D mutation is higher in normal population of Turkey than other Asian populations. For example, according to the study performed by Lin et al., allelic frequency of H63D mutation was 2.3% in normal Chinese Han population. 21 The investigators secreened the three HFE gene mutations in 395 normal individuals. 21 The allele frequencies of the H63D mutation among healthy control subjects were 7.8% in Korea, 3.2% in Tailand, 0.99 in Japan. [22] [23] [24] There is no clear evidence that H63D mutation leads to iron overload related to several diseases in some of the Asian populations. [25] [26] [27] In other investigations from the USA, Denmark, Canada, and Germany, H63D homozygotes were reported to have a high risk of having increased iron levels. [28] [29] [30] [31] Cogswell et al. found that transferrin saturation of the healthy people homozygous mutant for H63D aged 50 years or older had increased risk of iron overload than the younger ones (12-49 years). 32 Turkiye Klinikleri J Med Sci 2010;30 (6) The mean biochemical parameters in the cryptogenic cirrhotic patients and the control subjects in terms of normal, heterozygous and homozygous genotypes for the H63D mutation.
As a result, this mutation (H63D) may be responsible for the cryptogenic cirrhosis and hemochromatosis. The subjects carrying the H63D mutation should be periodically followed up in hepatology departments.
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